Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Zillow Group Inc Class C — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Zillow Group Inc Class C trades at $28.41 (market cap $6.33B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Zillow Group Inc Class C for 39 Days on average.
| HNGE | Z | |
|---|---|---|
Market Cap | $8.48B | $6.33B |
Volume | 879,799 | 4,060,713 |
Sector | Health | Media |
52-Week High | $105.14 | $78.04 |
52-Week Low | $31.17 | $27.13 |
Typical Hold Time | 0 Days | 39 Days |
Enterprise Value | $8.10B | $6.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Zillow Group (Z) trades at $27.97, showing modest daily gains but facing bearish technical signals with the current price near key support levels. The company demonstrates improving fundamentals with revenue growth from $2.2B in 2024 to $2.6B in 2025 and a return to profitability, though valuation metrics remain elevated with a P/E of 121.57. Recent developments include AI integration initiatives and resolution of FTC litigation, while the housing market faces affordability challenges.
The stock presents a mixed outlook with analyst consensus pointing to significant upside potential (average target $52) but near-term headwinds from housing market volatility. Investment opportunity lies in Zillow's platform transition and market leadership, balanced against risks from mortgage rate sensitivity and competitive pressures. The current price near 52-week lows may offer entry points for long-term investors believing in the housing tech transformation story.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
